vaccines
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.
University of Queensland Researchers Harness Nanopore Sequencing for mRNA Vaccine Quality Control
Premium
The researchers are now validating their workflow in partnership with Oxford Nanopore Technologies in order to commercialize the technology.
Oxford Nanopore, University of Queensland Partner for Sequencing-Based mRNA Vaccine Quality Control
Under the collaboration, researchers from UQ will use nanopore-based direct RNA sequencing to optimize the process of mRNA vaccine quality control.
Helix, CDC Partner to Study Genetics of Vaccine Effectiveness
The firm said the contract extends its public-private partnership with the US Centers for Disease Control and Prevention.
The results, statistically significant for the Pfizer/BioNTech vaccine, provide insight into early vaccine response and ways to personalize vaccinations.
Aug 16, 2021
Mar 12, 2021
Jul 5, 2018
Immunomonitor Consortium Receives €2M in Funding
Nov 27, 2017
Apr 11, 2017
Illumina Partners With Human Vaccines Project
Oct 4, 2016
Sep 13, 2016